Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Jeanne Galaine1, Yann Godet2, Olivier Adotévi3

  • 1INSERM, UMR1098, LabEx LipSTIC, F25000 Besançon, France; Univiversité de Bourgogne Franche-Comté, UMR1098, F25000 Besançon, France; EFS Bourgogne Franche-Comté, Plateforme de Biomonitoring, INSERM, CIC, 1431, F25000 Besançon, France.

Bulletin Du Cancer
|January 7, 2017
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Metformin dual-targets metabolism and survival pathways in BPDCN.

iScience·2026
Same author

Multidimensional immune profiling uncovers biphasic peripheral T-cell dynamics after chemoradiation in patients with locally advanced head and neck cancer.

Oncoimmunology·2026
Same author

Contribution of a specific panel by flow cytometry for the differential diagnosis of plasmacytoid dendritic cell neoplasms.

Annals of hematology·2026
Same author

Pivekimab sunirine in blastic plasmacytoid dendritic cell neoplasm: assessing spatial response and unraveling resistance mechanisms.

Haematologica·2026
Same author

Circulating Transcriptome Analysis Finds Gene Signatures and Immune Cell Activation and Abundance Predict Response to Immunotherapy in Bladder Cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

Evaluation of dasatinib and ponatinib for the control of CD123 CAR-T cell functionalities.

Molecular therapy. Oncology·2026

T cell activation, crucial for immunity, involves signals that promote effector functions or inhibit responses. Understanding these intricate T cell activation pathways aids in developing therapies for cancer and autoimmune diseases.

Area of Science:

  • Immunology
  • Cellular Biology
  • Cancer Research

Background:

  • T cell activation is essential for effective anti-infectious and antitumor immunity.
  • It must be tightly regulated to prevent autoimmune reactions.
  • T cells interact with other immune cells, notably dendritic cells, for activation.

Purpose of the Study:

  • To elucidate the mechanisms of T cell activation.
  • To explore the role of stimulatory and inhibitory signals in T cell responses.
  • To identify therapeutic targets for modulating T cell activity in disease.

Main Methods:

  • Analysis of T cell-dendritic cell interactions.
  • Investigation of T cell receptor (TCR) and peptide-MHC interactions.
  • Study of costimulatory and inhibitory receptor signaling pathways.
Keywords:
Cellules dendritiquesComplexe majeurCostimulatory moleculesDendritic cellsImmune checkpointsLymphocytes TMajor histocompatibilityMolécules dePoints de contrôleT cellscomplexcostimulationd’histocompatibilitéimmunologiques

Related Experiment Videos

Main Results:

  • T cell activation involves recognition of peptide-MHC by TCR.
  • Costimulatory molecules enhance T cell activation and immunological synapse formation.
  • Inhibitory receptors regulate T cell homeostasis and contribute to tumor immune evasion.

Conclusions:

  • Integration of stimulatory and inhibitory signals dictates T cell proliferation, survival, and differentiation.
  • Understanding these pathways is key to developing immunotherapies.
  • Targeting T cell activation mechanisms can enhance antitumor responses and manage autoimmunity.